Literature DB >> 2889501

Effects of sulphasalazine on faecal flora in patients with rheumatoid arthritis: a comparison with penicillamine.

V C Neumann1, R Shinebaum, E M Cooke, V Wright.   

Abstract

Twenty-six out-patients with active rheumatoid arthritis (RA) were randomly allocated to treatment with sulphasalazine (SASP) or D-penicillamine (DPA). Faecal samples were collected from all patients at 4-weekly intervals and examined for changes in faecal flora during treatment. Both treatment groups showed substantial clinical improvement. In the SASP-treated group this was accompanied by significant falls in counts of Cl. perfringens and E. coli. No such changes were seen in the DPA-treated group. These results suggest that SASP's efficacy in RA may be related to its antibacterial properties.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2889501     DOI: 10.1093/rheumatology/26.5.334

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  7 in total

Review 1.  Is there a role for antibiotics in the treatment of patients with rheumatoid arthritis?

Authors:  J R O'Dell
Journal:  Drugs       Date:  1999-03       Impact factor: 9.546

Review 2.  Rheumatoid arthritis, fasting, diet and bacteria: myths and enthusiasm.

Authors:  M T Nenonen
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 3.  Is the gut intrinsically abnormal in rheumatoid arthritis?

Authors:  A Doube; A J Collins
Journal:  Ann Rheum Dis       Date:  1988-08       Impact factor: 19.103

Review 4.  Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis.

Authors:  C P Rains; S Noble; D Faulds
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

5.  Effect of sulphasalazine and sulphapyridine on neutrophil superoxide production: role of cytosolic free calcium.

Authors:  L Kanerud; I Hafström; B Ringertz
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

Review 6.  Gut microbiota and rheumatoid arthritis: From pathogenesis to novel therapeutic opportunities.

Authors:  Ting Zhao; Yuanyuan Wei; Youyang Zhu; Zhaohu Xie; Qingshan Hai; Zhaofu Li; Dongdong Qin
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

Review 7.  DMARDs-Gut Microbiota Feedback: Implications in the Response to Therapy.

Authors:  Oscar Zaragoza-García; Natividad Castro-Alarcón; Gloria Pérez-Rubio; Iris Paola Guzmán-Guzmán
Journal:  Biomolecules       Date:  2020-10-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.